Noel Tata presents mega-offer from SP Group: give ₹25,000 crore, take 2-3% of Tata Sons

Sun Pharma’s June quarter results met analyst expectations, signaling future growth. The company is expanding its specialty and innovative medicines portfolio significantly. Strategic initiatives like semaglutide launches and the Organon acquisition are key drivers. Despite US generics pressure, domestic business and specialty products show strong momentum. Analysts maintain a positive outlook, anticipating substantial growth from…

Students protested their Azamgarh college, citing excessive fees and teacher shortages. They demanded a chemistry teacher, receiving assurances of one within forty-eight hours. Allegations of unreturned funds and management issues were also raised by supporters. The students seek fair treatment and better academic facilities from the institution. They warned of renewed protests if the chemistry…

Mustafa Suleyman, CEO of Microsoft AI, warns us about the potential dangers of uncontrolled AI systems, highlighting four critical capabilities that could lead to an urgent need for shutdown. He stresses the importance of oversight and regulation, emphasizing that features like self-improvement and independent resource acquisition could render AI unmanageable in just five to ten…